Amgen Inc. buy BMO Capital Markets
Start price
03.12.25
/
50%
€288.65
Target price
03.12.26
-
Performance (%)
2.23%
Price
15:56
€295.10
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets shows slight gains of 2.23%. This prediction currently runs until 03.12.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 4.016% | 4.016% |
| iShares Core DAX® | -1.933% | 2.239% |
| iShares Nasdaq 100 | -0.972% | 0.226% |
| iShares Nikkei 225® | -2.056% | 5.685% |
| iShares S&P 500 | -1.185% | 0.867% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.
Ratings data for AMGN provided by MarketBeat